CSI Market
Sign In | Register

Medicine Man Technologies inc (MDCL) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access MDCL Annual Cash Flow →
Cash flow data covering Medicine Man Technologies inc–Dec 31 2022 offers a view into how Dec 31 2023's cash position has developed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
12 Months 		(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Operating Activities
Income-34.55
Depreciation & amortization20.93
Amortization of Other Assets10.21
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories4.57
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets, Total1.97
Share-based Compensation3.59
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Equity Securities Received In Lieu Of Cash For Fees And Services Provided-
Non Cash Interest Expenses1.99
Goodwill And Intangible Asset Impairment-
Noncash Lease Expense3.32
Increase Decrease In Operating Lease Liability-2.66
Increase Decrease In Contract With Customer Liability-
Income taxes17.93
Losses/ -gains on Investments net-15.87
Increase (Decrease) in Accounts Receivable0.93
Increase (Decrease) in Accounts Payable and Other Operating Liabilities-3.24
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Prepaid Expense and Other Assets-0.51
Other Working Capital0.26
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities12.20
Investing Activities
Capital Expenditures-10.62
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Available For Sale Equity Securities Gross Unrealized Loss-
Property Plant And Equipment Transfers And Changes-
Issuance Of Notes Receivables-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Long-term Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross-15.83
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Proceeds from Collection of Finance Receivables0.01
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-26.44
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-5.35
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Payments For Statutory Withholdings On Restricted Stock Units-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-5.46
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow1.59
Total Cash Flow-19.70
4 historic quarters locked

Sign in to unlock the full Medicine Man Technologies inc cash flow history.

Sign In Create Free Account

About Medicine Man Technologies Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001558370-24-004104

Figures are derived from filed reports and may be restated. Historical data is subject to revision.